We are live on ! Find out more
JY

Jeff Yass Susquehanna International Group

AUM $1.28T
1-Year Est. Return 58.89%
 

Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.

This Fund
S&P 500
This Quarter Est. Return
+4.86%
1 Year Est. Return
+58.89%
3 Year Est. Return
+161.44%
5 Year Est. Return
+153.95%
10 Year Est. Return
+545.54%
AUM
$667B
AUM Growth
-$78.5B
Cap. Flow
-$15B
Cap. Flow %
-2.25%
Top 10 Hldgs %
32.39%
Holding
14,586
New
1,953
Increased
4,555
Reduced
6,197
Closed
1,571

Top Buys

Rank Stock Value
1
C icon
Citigroup
C
+$1.13B
2
T icon
AT&T
T
+$275M
3
AAPL icon
Apple
AAPL
+$248M
4
DIS icon
Walt Disney
DIS
+$235M
5
NKE icon
Nike
NKE
+$195M

Sector Composition

Rank Sector Weight
1 Miscellaneous 92.82%
2 Technology 1.6%
3 Consumer Discretionary 1.3%
4 Financials 0.99%
5 Communication Services 0.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CBIO
12451
CALL
Crescent Biopharma
CBIO
$660M
$53K ﹤0.01%
368
-411
-53% -$74.6K
JFIN
12452
PUT
Jiayin Group
JFIN
$114M
$53K ﹤0.01%
+24,300
New +$83.2K
LPTH icon
12453
Lightpath Technologies
LPTH
$866M
$53K ﹤0.01%
21,667
+8,216
+61% +$16.9K
LSAK icon
12454
Lesaka Technologies
LSAK
$391M
$53K ﹤0.01%
10,056
-46,778
-82% -$241K
NERV icon
12455
PUT
Minerva Neurosciences
NERV
$245M
$53K ﹤0.01%
8,350
-8,138
-49% -$76.6K
GENE
12456
PUT
DELISTED
Genetic Technologies Ltd.
GENE
$53K ﹤0.01%
5,680
-1,700
-23% -$21.8K
EAR
12457
CALL
DELISTED
Eargo, Inc. Common Stock
EAR
$53K ﹤0.01%
520
-7,665
-94% -$997K
BLRX
12458
PUT
BioLineRX
BLRX
$12.1M
$52K ﹤0.01%
643
-1,012
-61% -$105K
CIG icon
12459
PUT
CEMIG Preferred Shares
CIG
$5.64B
$52K ﹤0.01%
+35,997
New +$51.8K
DMAC icon
12460
DiaMedica Therapeutics
DMAC
$364M
$52K ﹤0.01%
14,065
-46,364
-77% -$182K
WVE icon
12461
Wave Life Sciences
WVE
$1.02B
$52K ﹤0.01%
16,670
+6,607
+66% +$27.4K
VCNX
12462
PUT
DELISTED
Vaccinex, Inc. Common Stock
VCNX
$52K ﹤0.01%
239
-397
-62% -$143K
GENE
12463
CALL
DELISTED
Genetic Technologies Ltd.
GENE
$52K ﹤0.01%
+5,520
New +$70.8K
NH
12464
DELISTED
NantHealth, Inc
NH
$52K ﹤0.01%
3,306
+2,618
+381% +$55.4K
SCLEW
12465
DELISTED
Broadscale Acquisition Corp. Warrant
SCLEW
$52K ﹤0.01%
+55,677
New +$51.7K
CXDO icon
12466
PUT
Crexendo
CXDO
$213M
$51K ﹤0.01%
+10,200
New +$54.9K
ITP icon
12467
IT Tech Packaging
ITP
$3.06M
$51K ﹤0.01%
22,186
-7,158
-24% -$24.1K
MIND icon
12468
MIND Technology
MIND
$40.4M
$51K ﹤0.01%
3,051
+15
+0.5% +$250
SNT
12469
Senstar Technologies
SNT
$39.9M
$51K ﹤0.01%
+17,412
New +$62.6K
YRD
12470
PUT
Yiren Digital
YRD
$94.5M
$51K ﹤0.01%
18,000
-8,300
-32% -$26.6K
VIRX
12471
PUT
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$51K ﹤0.01%
13,900
-1,600
-10% -$8.54K
GENE
12472
DELISTED
Genetic Technologies Ltd.
GENE
$51K ﹤0.01%
5,392
-1,642
-23% -$21K
YVR
12473
DELISTED
Liquid Media Group Ltd. Common Shares
YVR
$51K ﹤0.01%
12,095
-1,754
-13% -$9.92K
LJPC
12474
PUT
DELISTED
La Jolla Pharmaceutical Company
LJPC
$51K ﹤0.01%
10,900
-7,100
-39% -$29.6K
AQB icon
12475
CALL
AquaBounty Technologies
AQB
$6.74M
$50K ﹤0.01%
1,180
-4,065
-78% -$262K

Similar funds

Jeff Yass's Q4 2021 Portfolio in Review

As of Q4 2021, Jeff Yass held 14,586 positions worth $667B, down 11% from $745B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Jeff Yass's Q4 2021 filing shows 1,953 new, 4,555 increased, 6,197 reduced and 1,571 closed positions. Its largest new stake was iShares Core MSCI Emerging Markets ETF: 1,306,619 shares worth $78.2M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $2.4B.

By sector, the portfolio is most concentrated in Miscellaneous at 93% of assets, up from 93% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Jeff Yass's largest Q4 2021 buy was iShares Core MSCI Emerging Markets ETF: 1,306,619 shares worth $78.2M.
  • Jeff Yass added most to Citigroup in Q4 2021, an estimated $1.13B increase.
  • Jeff Yass's biggest Q4 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.4B.
  • Jeff Yass fully exited Stamps.com, Inc. in Q4 2021, selling an estimated $78.8M.
  • Jeff Yass's ten largest holdings make up 32% of its $667B portfolio in Q4 2021.
  • Jeff Yass opened 1,953 new positions and closed 1,571 in Q4 2021.
  • Jeff Yass's portfolio value fell 11% quarter-over-quarter to $667B.

Based on Susquehanna International Group's 13F filing for Q4 2021, filed 14 Feb 2022.